ACPU
STJ

Arrowgrass Capital Partners (US)’s St Jude Medical STJ Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,353,902
Closed -$189M – 668
2016
Q4 		$189M Buy
2,353,902
+98,618
+4% +$7.83M 2.13% 6
2016
Q3 		$180M Buy
+2,255,284
New +$182M 2.41% 7

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s STJ Position: Q1 2017 in Review

Arrowgrass Capital Partners (US) sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,353,902 shares — an estimated $189M sold.

Arrowgrass Capital Partners (US) first reported a position in STJ in Q3 2016 and held it in 2 quarters. The position peaked at $189M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Arrowgrass Capital Partners (US) reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 2,353,902 St Jude Medical shares in Q1 2017, an estimated $189M.
  • Arrowgrass Capital Partners (US) first reported a position in St Jude Medical in Q3 2016 and held it in 2 quarters.
  • Arrowgrass Capital Partners (US)'s St Jude Medical position peaked at $189M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2017, filed 15 May 2017.